22nd Century PE Ratio 2011-2024 | XXII

Current and historical p/e ratio for 22nd Century (XXII) from 2011 to 2024. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. 22nd Century PE ratio as of July 19, 2024 is 0.00.

Please refer to the Stock Price Adjustment Guide for more information on our historical prices.

22nd Century PE Ratio Historical Data
Date Stock Price TTM Net EPS PE Ratio
2024-07-19 0.84 0.00
2024-03-31 1.92 $-102.62 0.00
2023-12-31 2.98 $-118.87 0.00
2023-09-30 15.64 $-129.26 0.00
2023-06-30 91.85 $-84.77 0.00
2023-03-31 184.56 $-76.76 0.00
2022-12-31 220.92 $-69.57 0.00
2022-09-30 222.55 $-62.37 0.00
2022-06-30 511.20 $-62.37 0.00
2022-03-31 556.80 $-55.17 0.00
2021-12-31 741.60 $-50.37 0.00
2021-09-30 710.40 $-40.78 0.00
2021-06-30 1111.20 $-33.58 0.00
2021-03-31 789.60 $-35.98 0.00
2020-12-31 528.00 $-35.98 0.00
2020-09-30 153.79 $-35.98 0.00
2020-06-30 183.46 $-47.98 0.00
2020-03-31 180.00 $-52.77 0.00
2019-12-31 264.00 $-50.37 0.00
2019-09-30 542.40 $-55.17 0.00
2019-06-30 501.60 $-26.39 0.00
2019-03-31 410.40 $-23.99 0.00
2018-12-31 597.60 $-16.79 0.00
2018-09-30 674.40 0 0.00
2018-06-30 590.40 $-16.79 0.00
2018-03-31 564.00 $-14.39 0.00
2017-12-31 672.00 $-23.99 0.00
2017-09-30 664.80 $-31.18 0.00
2017-06-30 420.00 $-31.18 0.00
2017-03-31 283.20 $-31.18 0.00
2016-12-31 261.60 $-33.58 0.00
2016-09-30 348.00 $-35.98 0.00
2016-06-30 194.90 $-38.38 0.00
2016-03-31 187.92 $-33.58 0.00
2015-12-31 336.00 $-38.38 0.00
2015-09-30 201.60 $-50.37 0.00
2015-06-30 225.60 $-52.77 0.00
2015-03-31 206.40 $-55.17 0.00
2014-12-31 396.00 $-62.37 0.00
2014-09-30 604.80 $-79.16 0.00
2014-06-30 736.80 $-143.93 0.00
2014-03-31 780.00 $-139.13 0.00
2013-12-31 513.60 $-117.54 0.00
2013-09-30 309.60 $-79.16 0.00
2013-06-30 170.40 $-2.40 0.00
2013-03-31 211.20 0 0.00
2012-12-31 180.00 $-19.19 0.00
2012-09-30 67.20 $-19.19 0.00
2012-06-30 84.00 $-28.79 0.00
2012-03-31 148.80 $-28.79 0.00
2011-12-31 100.80 $-14.39 0.00
Sector Industry Market Cap Revenue
Consumer Staples Tobacco Products $0.007B $0.032B
22nd Century Group, Inc. is a plant biotechnology company focused on decreasing/increasing the level of nicotine in the tobacco plant through genetic engineering and breeding. The Company is focused on development of smoking cessation aid and owns and controls several patents. The company's products include X-22, a prescription smoking cessation aid, which is a tobacco-based botanical medical product for use as a smoking cessation therapy. 22nd Century Group, Inc. is based in Williamsville, New York.
Stock Name Country Market Cap PE Ratio
Philip Morris (PM) United States $166.524B 17.47
Altria (MO) United States $84.937B 10.05
British American Tobacco (BTI) United Kingdom $73.740B 0.00
Imperial Tobacco Group (IMBBY) United Kingdom $23.230B 0.00
Universal (UVV) United States $1.254B 10.01
Turning Point Brands (TPB) United States $0.644B 12.77